Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Retinopathy of Prematurity | 45 | 2024 | 449 | 9.540 |
Why?
|
Electroretinography | 82 | 2023 | 522 | 7.480 |
Why?
|
Retinal Rod Photoreceptor Cells | 35 | 2016 | 204 | 6.850 |
Why?
|
Dark Adaptation | 70 | 2024 | 223 | 6.120 |
Why?
|
Retina | 59 | 2024 | 2646 | 3.740 |
Why?
|
Retinal Cone Photoreceptor Cells | 13 | 2020 | 183 | 3.260 |
Why?
|
Refractive Errors | 10 | 2024 | 148 | 3.240 |
Why?
|
Retinoschisis | 6 | 2023 | 29 | 2.990 |
Why?
|
Visual Acuity | 46 | 2024 | 2672 | 2.920 |
Why?
|
Myopia | 13 | 2025 | 254 | 2.760 |
Why?
|
Sensory Thresholds | 33 | 2016 | 377 | 2.430 |
Why?
|
Vision, Ocular | 23 | 2021 | 457 | 2.280 |
Why?
|
Fovea Centralis | 11 | 2022 | 121 | 2.170 |
Why?
|
Visual Fields | 13 | 2024 | 1062 | 1.850 |
Why?
|
Retinal Degeneration | 15 | 2017 | 413 | 1.700 |
Why?
|
Retinal Diseases | 13 | 2023 | 702 | 1.680 |
Why?
|
Leber Congenital Amaurosis | 4 | 2024 | 36 | 1.660 |
Why?
|
Night Blindness | 5 | 2025 | 58 | 1.570 |
Why?
|
Photoreceptor Cells, Vertebrate | 6 | 2019 | 203 | 1.420 |
Why?
|
Tomography, Optical Coherence | 10 | 2024 | 2877 | 1.370 |
Why?
|
Hyperopia | 5 | 2023 | 41 | 1.320 |
Why?
|
Eye Proteins | 6 | 2024 | 628 | 1.310 |
Why?
|
Bardet-Biedl Syndrome | 6 | 2024 | 51 | 1.300 |
Why?
|
Eye | 10 | 2023 | 710 | 1.300 |
Why?
|
Retinitis Pigmentosa | 7 | 2023 | 392 | 1.300 |
Why?
|
Retinal Vessels | 10 | 2021 | 848 | 1.260 |
Why?
|
Vigabatrin | 3 | 2015 | 88 | 1.160 |
Why?
|
Visual Field Tests | 8 | 2024 | 413 | 1.160 |
Why?
|
Macular Degeneration | 3 | 2021 | 1002 | 1.150 |
Why?
|
Retinal Dystrophies | 3 | 2024 | 63 | 1.130 |
Why?
|
Eye Diseases, Hereditary | 4 | 2025 | 124 | 1.080 |
Why?
|
Photic Stimulation | 27 | 2019 | 1989 | 1.060 |
Why?
|
Refraction, Ocular | 11 | 2025 | 188 | 1.040 |
Why?
|
Photophobia | 4 | 2019 | 77 | 1.030 |
Why?
|
Rhodopsin | 17 | 2009 | 202 | 0.910 |
Why?
|
Evoked Potentials, Visual | 10 | 2021 | 417 | 0.890 |
Why?
|
Genetic Diseases, X-Linked | 4 | 2025 | 386 | 0.880 |
Why?
|
Ophthalmoscopy | 6 | 2020 | 170 | 0.880 |
Why?
|
Retinal Neovascularization | 4 | 2013 | 286 | 0.880 |
Why?
|
Infant, Newborn | 62 | 2024 | 26381 | 0.880 |
Why?
|
Infant | 88 | 2025 | 36427 | 0.860 |
Why?
|
Color Vision | 2 | 2019 | 23 | 0.820 |
Why?
|
Visual Perception | 10 | 2014 | 1392 | 0.820 |
Why?
|
Choroid Diseases | 1 | 2023 | 60 | 0.810 |
Why?
|
Adaptation, Ocular | 11 | 2008 | 89 | 0.790 |
Why?
|
Esotropia | 5 | 2018 | 99 | 0.780 |
Why?
|
Corneal Dystrophies, Hereditary | 1 | 2023 | 62 | 0.780 |
Why?
|
Contact Lenses | 1 | 2023 | 137 | 0.750 |
Why?
|
Photoreceptor Cells | 16 | 2024 | 234 | 0.740 |
Why?
|
Child | 80 | 2025 | 80573 | 0.700 |
Why?
|
Disease Models, Animal | 18 | 2024 | 18321 | 0.670 |
Why?
|
Albinism, Ocular | 2 | 2017 | 7 | 0.660 |
Why?
|
Vision Disorders | 13 | 2024 | 1087 | 0.650 |
Why?
|
Choroideremia | 1 | 2019 | 23 | 0.650 |
Why?
|
Microcephaly | 1 | 2023 | 427 | 0.630 |
Why?
|
Retinal Pigments | 11 | 2002 | 83 | 0.630 |
Why?
|
Retinal Ganglion Cells | 3 | 2019 | 808 | 0.620 |
Why?
|
Macula Lutea | 5 | 2017 | 168 | 0.600 |
Why?
|
Gestational Age | 13 | 2024 | 3616 | 0.600 |
Why?
|
Anticonvulsants | 3 | 2015 | 1920 | 0.590 |
Why?
|
Exotropia | 1 | 2018 | 64 | 0.590 |
Why?
|
Child, Preschool | 66 | 2025 | 42511 | 0.580 |
Why?
|
Albinism | 3 | 2021 | 25 | 0.580 |
Why?
|
Psychophysics | 17 | 2019 | 292 | 0.570 |
Why?
|
Vitelliform Macular Dystrophy | 1 | 2017 | 10 | 0.570 |
Why?
|
Smith-Lemli-Opitz Syndrome | 2 | 2010 | 46 | 0.560 |
Why?
|
Hemianopsia | 1 | 2018 | 121 | 0.560 |
Why?
|
Nerve Tissue Proteins | 3 | 2024 | 4399 | 0.550 |
Why?
|
Membrane Proteins | 7 | 2024 | 7850 | 0.550 |
Why?
|
Oxygen | 13 | 2016 | 4247 | 0.550 |
Why?
|
Adolescent | 69 | 2025 | 88819 | 0.530 |
Why?
|
Infant, Premature | 7 | 2017 | 2121 | 0.530 |
Why?
|
Albinism, Oculocutaneous | 4 | 2022 | 19 | 0.530 |
Why?
|
Rats | 36 | 2016 | 23717 | 0.510 |
Why?
|
Ophthalmology | 2 | 2021 | 559 | 0.510 |
Why?
|
Encephalocele | 1 | 2017 | 135 | 0.500 |
Why?
|
Humans | 200 | 2025 | 766117 | 0.490 |
Why?
|
Thalamus | 2 | 2019 | 1040 | 0.490 |
Why?
|
Rats, Sprague-Dawley | 19 | 2016 | 8113 | 0.470 |
Why?
|
Retinal Pigment Epithelium | 2 | 2015 | 298 | 0.460 |
Why?
|
Mydriatics | 4 | 2022 | 67 | 0.450 |
Why?
|
Animals, Newborn | 15 | 2016 | 2677 | 0.450 |
Why?
|
Anterior Eye Segment | 2 | 2022 | 144 | 0.450 |
Why?
|
Migraine Disorders | 4 | 2019 | 1712 | 0.440 |
Why?
|
Hermanski-Pudlak Syndrome | 1 | 2013 | 20 | 0.440 |
Why?
|
Blindness, Cortical | 2 | 2005 | 17 | 0.440 |
Why?
|
Blood Coagulation Disorders, Inherited | 1 | 2013 | 19 | 0.440 |
Why?
|
Eye Abnormalities | 3 | 2021 | 242 | 0.430 |
Why?
|
Glaucoma | 2 | 2023 | 1194 | 0.420 |
Why?
|
Ophthalmoscopes | 1 | 2012 | 21 | 0.420 |
Why?
|
Term Birth | 2 | 2015 | 140 | 0.420 |
Why?
|
Retinal Artery | 3 | 2013 | 109 | 0.420 |
Why?
|
Retinal Detachment | 1 | 2017 | 426 | 0.400 |
Why?
|
Vision Tests | 13 | 2005 | 159 | 0.380 |
Why?
|
Diabetic Retinopathy | 1 | 2021 | 1294 | 0.380 |
Why?
|
Laser Coagulation | 3 | 2023 | 334 | 0.380 |
Why?
|
Amino Acid Transport Systems, Neutral | 2 | 2022 | 42 | 0.370 |
Why?
|
Astigmatism | 6 | 2024 | 69 | 0.370 |
Why?
|
Optic Disk | 2 | 2022 | 420 | 0.360 |
Why?
|
Arterioles | 3 | 2013 | 251 | 0.350 |
Why?
|
Intravitreal Injections | 2 | 2023 | 391 | 0.350 |
Why?
|
Optic Atrophies, Hereditary | 6 | 2011 | 27 | 0.350 |
Why?
|
Pigment Epithelium of Eye | 7 | 1999 | 209 | 0.340 |
Why?
|
Blindness | 6 | 2016 | 584 | 0.340 |
Why?
|
Fourier Analysis | 2 | 2008 | 434 | 0.340 |
Why?
|
Light | 13 | 2018 | 1358 | 0.340 |
Why?
|
Aging | 21 | 2024 | 8723 | 0.320 |
Why?
|
Rod Cell Outer Segment | 6 | 1999 | 50 | 0.320 |
Why?
|
Adult | 72 | 2024 | 223139 | 0.320 |
Why?
|
Deferoxamine | 2 | 2007 | 154 | 0.310 |
Why?
|
Neural Pathways | 2 | 2019 | 3079 | 0.310 |
Why?
|
Intracranial Hypertension | 2 | 2022 | 190 | 0.310 |
Why?
|
Eye Diseases | 10 | 2014 | 660 | 0.310 |
Why?
|
Ocular Physiological Phenomena | 2 | 2005 | 67 | 0.310 |
Why?
|
Color Vision Defects | 1 | 2008 | 28 | 0.310 |
Why?
|
Retinal Vein | 2 | 2005 | 46 | 0.290 |
Why?
|
Alagille Syndrome | 1 | 2007 | 45 | 0.280 |
Why?
|
Siderophores | 1 | 2007 | 61 | 0.280 |
Why?
|
Visual Pathways | 5 | 2021 | 554 | 0.280 |
Why?
|
Young Adult | 18 | 2024 | 59868 | 0.270 |
Why?
|
Scotoma | 1 | 2007 | 128 | 0.270 |
Why?
|
Animals | 49 | 2024 | 168800 | 0.270 |
Why?
|
Child Development | 6 | 2009 | 2327 | 0.260 |
Why?
|
Methylmalonic Acid | 2 | 2005 | 50 | 0.260 |
Why?
|
Pupil | 3 | 2001 | 147 | 0.260 |
Why?
|
Male | 63 | 2025 | 363935 | 0.250 |
Why?
|
Homocystinuria | 2 | 2005 | 66 | 0.240 |
Why?
|
Electrophysiology | 4 | 2018 | 1263 | 0.240 |
Why?
|
Usher Syndromes | 2 | 2021 | 56 | 0.240 |
Why?
|
Cyclopentolate | 2 | 2001 | 6 | 0.240 |
Why?
|
Female | 62 | 2025 | 396233 | 0.240 |
Why?
|
Vision, Low | 2 | 2021 | 162 | 0.240 |
Why?
|
Amblyopia | 7 | 1988 | 152 | 0.240 |
Why?
|
Visually Impaired Persons | 1 | 2005 | 79 | 0.230 |
Why?
|
Kearns-Sayre Syndrome | 1 | 2024 | 6 | 0.230 |
Why?
|
Lasers | 2 | 2023 | 951 | 0.230 |
Why?
|
Electrooculography | 2 | 2018 | 112 | 0.230 |
Why?
|
Axoneme | 1 | 2024 | 26 | 0.230 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2005 | 119 | 0.230 |
Why?
|
Oscillometry | 4 | 2008 | 151 | 0.230 |
Why?
|
Ciliary Motility Disorders | 1 | 2024 | 51 | 0.220 |
Why?
|
Centrioles | 1 | 2024 | 80 | 0.220 |
Why?
|
TRPM Cation Channels | 1 | 2025 | 139 | 0.220 |
Why?
|
Tiletamine | 1 | 2003 | 2 | 0.220 |
Why?
|
Zolazepam | 1 | 2003 | 2 | 0.220 |
Why?
|
Light Signal Transduction | 1 | 2023 | 31 | 0.220 |
Why?
|
Electrodes | 2 | 2008 | 610 | 0.210 |
Why?
|
Pentobarbital | 1 | 2003 | 153 | 0.210 |
Why?
|
Fundus Oculi | 2 | 2002 | 543 | 0.210 |
Why?
|
Laurence-Moon Syndrome | 3 | 1993 | 9 | 0.210 |
Why?
|
Anesthetics, Dissociative | 1 | 2003 | 81 | 0.210 |
Why?
|
Cerebral Cortex | 2 | 2019 | 5758 | 0.210 |
Why?
|
Angiogenesis Inhibitors | 2 | 2023 | 2046 | 0.200 |
Why?
|
Cyclic GMP | 1 | 2023 | 394 | 0.200 |
Why?
|
Galvanic Skin Response | 1 | 2004 | 359 | 0.200 |
Why?
|
Optic Atrophy, Hereditary, Leber | 3 | 2009 | 50 | 0.200 |
Why?
|
Nerve Growth Factor | 1 | 2023 | 156 | 0.190 |
Why?
|
Retrospective Studies | 13 | 2025 | 81565 | 0.190 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2005 | 361 | 0.190 |
Why?
|
Fluorescein Angiography | 3 | 2021 | 1050 | 0.190 |
Why?
|
Retinal Neurons | 2 | 2013 | 66 | 0.190 |
Why?
|
Nystagmus, Congenital | 1 | 2021 | 9 | 0.190 |
Why?
|
Myasthenia Gravis | 1 | 2024 | 214 | 0.190 |
Why?
|
Child Abuse, Sexual | 1 | 2024 | 398 | 0.190 |
Why?
|
Optic Nerve Diseases | 4 | 2019 | 342 | 0.180 |
Why?
|
beta-Thalassemia | 2 | 2007 | 233 | 0.180 |
Why?
|
Pseudotumor Cerebri | 1 | 2022 | 107 | 0.180 |
Why?
|
Calcium Channels, L-Type | 2 | 2025 | 243 | 0.180 |
Why?
|
Neurons | 3 | 2016 | 9521 | 0.180 |
Why?
|
Administration, Topical | 1 | 2023 | 702 | 0.180 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2005 | 698 | 0.180 |
Why?
|
Tubulin | 1 | 2024 | 694 | 0.170 |
Why?
|
Carbonic Anhydrase Inhibitors | 1 | 2020 | 93 | 0.170 |
Why?
|
Vestibular Diseases | 1 | 2023 | 232 | 0.170 |
Why?
|
Night Vision | 1 | 2019 | 7 | 0.170 |
Why?
|
Rats, Long-Evans | 3 | 2016 | 380 | 0.170 |
Why?
|
Cilia | 1 | 2024 | 498 | 0.170 |
Why?
|
cis-trans-Isomerases | 3 | 2016 | 44 | 0.170 |
Why?
|
Phenotype | 8 | 2023 | 16716 | 0.170 |
Why?
|
Premature Birth | 4 | 2015 | 1830 | 0.160 |
Why?
|
Microtubule-Associated Proteins | 3 | 2023 | 1068 | 0.160 |
Why?
|
Ischemia | 1 | 2008 | 1904 | 0.160 |
Why?
|
Nystagmus, Pathologic | 2 | 2017 | 104 | 0.160 |
Why?
|
Muscle Hypotonia | 1 | 2020 | 166 | 0.160 |
Why?
|
Rod Opsins | 4 | 2008 | 108 | 0.160 |
Why?
|
Fixation, Ocular | 3 | 2019 | 243 | 0.160 |
Why?
|
Cornea | 3 | 2015 | 1315 | 0.160 |
Why?
|
Photography | 1 | 2002 | 535 | 0.160 |
Why?
|
Mitochondrial Diseases | 1 | 2002 | 344 | 0.150 |
Why?
|
Infant, Premature, Diseases | 4 | 2013 | 712 | 0.150 |
Why?
|
Mutation | 14 | 2024 | 30209 | 0.150 |
Why?
|
Gene Duplication | 1 | 1999 | 316 | 0.140 |
Why?
|
Aconitate Hydratase | 1 | 2017 | 17 | 0.140 |
Why?
|
Color Perception | 1 | 2018 | 211 | 0.140 |
Why?
|
Spasms, Infantile | 1 | 2021 | 300 | 0.140 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2024 | 858 | 0.140 |
Why?
|
Electrodiagnosis | 1 | 2018 | 149 | 0.140 |
Why?
|
Cell Adhesion Molecules | 1 | 2023 | 1610 | 0.140 |
Why?
|
Abnormalities, Multiple | 3 | 2023 | 1424 | 0.140 |
Why?
|
Walking | 1 | 2024 | 1198 | 0.140 |
Why?
|
Lens, Crystalline | 3 | 2015 | 387 | 0.130 |
Why?
|
Retinal Vein Occlusion | 1 | 1997 | 147 | 0.130 |
Why?
|
Nephrosis | 1 | 2016 | 43 | 0.130 |
Why?
|
Optic Nerve | 1 | 2019 | 568 | 0.130 |
Why?
|
Cell Count | 2 | 2016 | 1825 | 0.130 |
Why?
|
Disease Progression | 5 | 2025 | 13616 | 0.120 |
Why?
|
Birth Weight | 4 | 2024 | 2122 | 0.120 |
Why?
|
Hypnotics and Sedatives | 1 | 2003 | 1193 | 0.120 |
Why?
|
Craniosynostoses | 1 | 2019 | 415 | 0.120 |
Why?
|
Hyperoxia | 2 | 2007 | 259 | 0.120 |
Why?
|
Ataxia | 1 | 2017 | 307 | 0.120 |
Why?
|
Acetazolamide | 1 | 1995 | 98 | 0.120 |
Why?
|
Cell Shape | 1 | 2016 | 372 | 0.120 |
Why?
|
Visual Cortex | 3 | 2019 | 1081 | 0.120 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2022 | 2879 | 0.120 |
Why?
|
Nystagmus, Optokinetic | 1 | 1994 | 31 | 0.110 |
Why?
|
Developmental Disabilities | 3 | 2020 | 1519 | 0.110 |
Why?
|
Genotype | 6 | 2025 | 13028 | 0.110 |
Why?
|
Persistent Hyperplastic Primary Vitreous | 1 | 2013 | 7 | 0.110 |
Why?
|
Epilepsy | 1 | 2009 | 3317 | 0.110 |
Why?
|
Retinal Bipolar Cells | 2 | 2016 | 45 | 0.110 |
Why?
|
Oxidoreductases | 2 | 2008 | 409 | 0.110 |
Why?
|
Mice, Knockout | 3 | 2024 | 14456 | 0.100 |
Why?
|
Point Mutation | 1 | 2017 | 1591 | 0.100 |
Why?
|
Halothane | 1 | 1992 | 200 | 0.100 |
Why?
|
Family | 1 | 2023 | 3208 | 0.100 |
Why?
|
Nystagmus, Physiologic | 2 | 2009 | 29 | 0.100 |
Why?
|
Biometry | 1 | 2015 | 571 | 0.100 |
Why?
|
Vision Screening | 1 | 1992 | 72 | 0.090 |
Why?
|
Membrane Transport Proteins | 2 | 2008 | 1029 | 0.090 |
Why?
|
Cohort Studies | 5 | 2023 | 41684 | 0.090 |
Why?
|
Frameshift Mutation | 3 | 2017 | 392 | 0.090 |
Why?
|
Space Perception | 1 | 1994 | 469 | 0.090 |
Why?
|
Carrier Proteins | 3 | 2016 | 4910 | 0.090 |
Why?
|
Occlusive Dressings | 2 | 1988 | 52 | 0.090 |
Why?
|
Hereditary Sensory and Motor Neuropathy | 1 | 1990 | 22 | 0.090 |
Why?
|
Blotting, Western | 2 | 2015 | 5020 | 0.090 |
Why?
|
Functional Laterality | 2 | 2016 | 2244 | 0.090 |
Why?
|
Diagnostic Errors | 1 | 2017 | 1276 | 0.090 |
Why?
|
Reference Values | 5 | 2003 | 4909 | 0.080 |
Why?
|
Syndrome | 6 | 2022 | 3270 | 0.080 |
Why?
|
Cross-Sectional Studies | 5 | 2024 | 26290 | 0.080 |
Why?
|
DNA | 3 | 2022 | 7193 | 0.080 |
Why?
|
Injections, Intraperitoneal | 1 | 2010 | 410 | 0.080 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2011 | 237 | 0.080 |
Why?
|
Proteomics | 1 | 2023 | 3907 | 0.080 |
Why?
|
Choroid | 2 | 1991 | 352 | 0.080 |
Why?
|
Hydrocephalus | 1 | 2016 | 766 | 0.080 |
Why?
|
Follow-Up Studies | 4 | 2024 | 39243 | 0.080 |
Why?
|
Medical Records | 2 | 2010 | 1408 | 0.080 |
Why?
|
Kinetics | 3 | 2005 | 6273 | 0.080 |
Why?
|
Strabismus | 5 | 1988 | 320 | 0.080 |
Why?
|
DNA Mutational Analysis | 5 | 2022 | 4112 | 0.080 |
Why?
|
Acetamides | 1 | 2010 | 260 | 0.080 |
Why?
|
Hyperprolactinemia | 1 | 1989 | 123 | 0.070 |
Why?
|
Carotenoids | 1 | 2011 | 620 | 0.070 |
Why?
|
Middle Aged | 20 | 2022 | 223083 | 0.070 |
Why?
|
Eye Movements | 3 | 1987 | 510 | 0.070 |
Why?
|
Adaptation, Physiological | 3 | 1988 | 1310 | 0.070 |
Why?
|
DNA, Mitochondrial | 2 | 2024 | 870 | 0.070 |
Why?
|
Language | 1 | 2016 | 1550 | 0.070 |
Why?
|
Cognition | 2 | 2023 | 7050 | 0.070 |
Why?
|
Apraxias | 1 | 1987 | 58 | 0.070 |
Why?
|
Hydroxocobalamin | 2 | 2005 | 27 | 0.070 |
Why?
|
Dopamine | 1 | 2013 | 1582 | 0.070 |
Why?
|
Algorithms | 2 | 2024 | 14066 | 0.070 |
Why?
|
Densitometry | 5 | 1988 | 150 | 0.070 |
Why?
|
Age Factors | 17 | 2009 | 18386 | 0.070 |
Why?
|
Genetic Testing | 3 | 2017 | 3594 | 0.070 |
Why?
|
Signal Transduction | 4 | 2013 | 23605 | 0.070 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2662 | 0.070 |
Why?
|
Proteins | 5 | 2016 | 5995 | 0.060 |
Why?
|
Venules | 1 | 2006 | 161 | 0.060 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2019 | 1898 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3665 | 0.060 |
Why?
|
Mice | 9 | 2024 | 81839 | 0.060 |
Why?
|
Cobamides | 1 | 2005 | 12 | 0.060 |
Why?
|
Ophthalmoplegia | 1 | 1987 | 168 | 0.060 |
Why?
|
Saccades | 1 | 1987 | 230 | 0.060 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 2 | 2005 | 284 | 0.060 |
Why?
|
Betaine | 1 | 2005 | 90 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2013 | 6208 | 0.060 |
Why?
|
Pedigree | 6 | 2016 | 4535 | 0.060 |
Why?
|
Professional Practice | 1 | 2006 | 314 | 0.060 |
Why?
|
Equipment Design | 1 | 2012 | 3489 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3690 | 0.060 |
Why?
|
Receptor, Notch1 | 1 | 2007 | 516 | 0.060 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2744 | 0.060 |
Why?
|
Chromosomes, Human, X | 1 | 2006 | 319 | 0.060 |
Why?
|
Pigmentation Disorders | 2 | 1982 | 105 | 0.060 |
Why?
|
Methionine | 2 | 2005 | 569 | 0.050 |
Why?
|
Metabolism, Inborn Errors | 1 | 2006 | 291 | 0.050 |
Why?
|
Photometry | 3 | 1991 | 55 | 0.050 |
Why?
|
Time Factors | 11 | 2010 | 40108 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8038 | 0.050 |
Why?
|
Cytoskeletal Proteins | 2 | 2021 | 1322 | 0.050 |
Why?
|
Infant, Low Birth Weight | 1 | 2008 | 870 | 0.050 |
Why?
|
Prospective Studies | 3 | 2023 | 54812 | 0.050 |
Why?
|
Calcium-Binding Proteins | 1 | 2007 | 1077 | 0.050 |
Why?
|
RNA, Messenger | 3 | 2013 | 12775 | 0.050 |
Why?
|
Homocysteine | 1 | 2005 | 638 | 0.050 |
Why?
|
Microspectrophotometry | 2 | 1999 | 4 | 0.050 |
Why?
|
Pediatrics | 2 | 2006 | 3609 | 0.050 |
Why?
|
Proteoglycans | 1 | 2025 | 794 | 0.050 |
Why?
|
Prevalence | 1 | 2018 | 15827 | 0.050 |
Why?
|
Area Under Curve | 1 | 2005 | 1638 | 0.050 |
Why?
|
Nervous System Diseases | 1 | 2012 | 1657 | 0.050 |
Why?
|
Conserved Sequence | 2 | 2003 | 1159 | 0.050 |
Why?
|
Mitochondria, Muscle | 1 | 2002 | 170 | 0.050 |
Why?
|
Cholesterol | 1 | 2010 | 2902 | 0.050 |
Why?
|
GTP Phosphohydrolases | 1 | 2024 | 524 | 0.050 |
Why?
|
Phenylacetates | 1 | 1980 | 112 | 0.040 |
Why?
|
Ligands | 1 | 2007 | 3274 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7424 | 0.040 |
Why?
|
Heart Defects, Congenital | 1 | 1997 | 4712 | 0.040 |
Why?
|
Chromosomes, Human, 16-18 | 1 | 1980 | 32 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2007 | 1656 | 0.040 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 2020 | 228 | 0.040 |
Why?
|
Histone Demethylases | 1 | 2023 | 328 | 0.040 |
Why?
|
GTP-Binding Proteins | 1 | 2024 | 945 | 0.040 |
Why?
|
Sensitivity and Specificity | 3 | 2014 | 14645 | 0.040 |
Why?
|
Chickens | 1 | 1982 | 842 | 0.040 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2008 | 3606 | 0.040 |
Why?
|
Neonatal Screening | 1 | 2024 | 619 | 0.040 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2001 | 340 | 0.040 |
Why?
|
Homozygote | 2 | 2020 | 1774 | 0.040 |
Why?
|
Vitamin A | 1 | 1982 | 611 | 0.040 |
Why?
|
Comparative Genomic Hybridization | 1 | 2020 | 474 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2024 | 1716 | 0.040 |
Why?
|
Recovery of Function | 1 | 2009 | 2971 | 0.040 |
Why?
|
Haplorhini | 1 | 1999 | 520 | 0.040 |
Why?
|
Trisomy | 1 | 1980 | 260 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2010 | 15882 | 0.040 |
Why?
|
Dietary Supplements | 1 | 2011 | 3427 | 0.040 |
Why?
|
Urodela | 1 | 1978 | 18 | 0.040 |
Why?
|
Deer | 1 | 1977 | 14 | 0.040 |
Why?
|
Feasibility Studies | 1 | 2009 | 5300 | 0.040 |
Why?
|
Anophthalmos | 1 | 1977 | 23 | 0.040 |
Why?
|
ROC Curve | 1 | 2005 | 3614 | 0.040 |
Why?
|
Membrane Glycoproteins | 1 | 2008 | 3692 | 0.040 |
Why?
|
Phagosomes | 1 | 1999 | 193 | 0.040 |
Why?
|
Glaucoma, Neovascular | 1 | 1997 | 37 | 0.040 |
Why?
|
Brain | 3 | 2017 | 27177 | 0.040 |
Why?
|
Polyploidy | 1 | 1977 | 120 | 0.040 |
Why?
|
Microphthalmos | 1 | 1977 | 58 | 0.030 |
Why?
|
International Agencies | 1 | 2018 | 241 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2008 | 3501 | 0.030 |
Why?
|
Attention | 2 | 1987 | 2415 | 0.030 |
Why?
|
Prognosis | 2 | 2015 | 29912 | 0.030 |
Why?
|
Cystic Fibrosis | 2 | 1985 | 1284 | 0.030 |
Why?
|
Drug Combinations | 1 | 2003 | 2076 | 0.030 |
Why?
|
Eye Manifestations | 1 | 1976 | 10 | 0.030 |
Why?
|
Differential Threshold | 2 | 1992 | 80 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 4 | 2024 | 36548 | 0.030 |
Why?
|
Cryosurgery | 2 | 1995 | 479 | 0.030 |
Why?
|
Heterozygote | 1 | 2003 | 2796 | 0.030 |
Why?
|
Mathematical Concepts | 1 | 2016 | 77 | 0.030 |
Why?
|
Chelating Agents | 1 | 1998 | 380 | 0.030 |
Why?
|
Calibration | 2 | 2008 | 813 | 0.030 |
Why?
|
Exons | 2 | 1999 | 2393 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2020 | 1384 | 0.030 |
Why?
|
Coloboma | 2 | 1991 | 60 | 0.030 |
Why?
|
Age Distribution | 1 | 2001 | 2865 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 1999 | 1695 | 0.030 |
Why?
|
Acute Disease | 3 | 2001 | 7237 | 0.030 |
Why?
|
Aerobiosis | 1 | 1995 | 100 | 0.030 |
Why?
|
Chromosome Mapping | 2 | 2020 | 4617 | 0.030 |
Why?
|
Nerve Fibers | 1 | 2019 | 704 | 0.030 |
Why?
|
Axial Length, Eye | 1 | 2015 | 36 | 0.030 |
Why?
|
Posterior Eye Segment | 1 | 2015 | 18 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11906 | 0.030 |
Why?
|
Chromosome Disorders | 1 | 1977 | 498 | 0.030 |
Why?
|
Laser Therapy | 2 | 1995 | 1108 | 0.030 |
Why?
|
Anterior Chamber | 1 | 2015 | 194 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2020 | 2510 | 0.030 |
Why?
|
3,4-Dihydroxyphenylacetic Acid | 1 | 2013 | 60 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2018 | 22228 | 0.030 |
Why?
|
Retinoscopy | 1 | 2013 | 27 | 0.030 |
Why?
|
Problem Solving | 1 | 2016 | 442 | 0.030 |
Why?
|
Music | 1 | 2016 | 248 | 0.030 |
Why?
|
Cattle | 1 | 1999 | 3801 | 0.030 |
Why?
|
Child Health Services | 1 | 1979 | 645 | 0.030 |
Why?
|
Spectrophotometry | 2 | 1990 | 291 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2014 | 20137 | 0.030 |
Why?
|
Aspartic Acid | 1 | 1995 | 575 | 0.030 |
Why?
|
Conjunctiva | 1 | 1976 | 477 | 0.030 |
Why?
|
Giant Cell Arteritis | 1 | 1976 | 308 | 0.020 |
Why?
|
Chediak-Higashi Syndrome | 1 | 1992 | 10 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2001 | 2430 | 0.020 |
Why?
|
Mutation, Missense | 2 | 2017 | 2590 | 0.020 |
Why?
|
Polysomnography | 1 | 2019 | 1868 | 0.020 |
Why?
|
Down Syndrome | 1 | 2020 | 915 | 0.020 |
Why?
|
Trans-Activators | 1 | 2001 | 2849 | 0.020 |
Why?
|
Polymorphism, Single-Stranded Conformational | 2 | 2002 | 325 | 0.020 |
Why?
|
Drosophila Proteins | 1 | 2001 | 1704 | 0.020 |
Why?
|
Inflammation | 1 | 2011 | 10860 | 0.020 |
Why?
|
Pregnancy | 1 | 2013 | 30233 | 0.020 |
Why?
|
Intraocular Pressure | 1 | 1997 | 1304 | 0.020 |
Why?
|
Rats, Mutant Strains | 1 | 1991 | 59 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 1977 | 1775 | 0.020 |
Why?
|
Aged | 9 | 2022 | 171219 | 0.020 |
Why?
|
Blood Transfusion | 1 | 1998 | 1307 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2024 | 12976 | 0.020 |
Why?
|
Sarcoidosis | 1 | 1976 | 535 | 0.020 |
Why?
|
Random Allocation | 1 | 1995 | 2395 | 0.020 |
Why?
|
Rats, Inbred Strains | 4 | 1987 | 2077 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2013 | 1527 | 0.020 |
Why?
|
Uveal Diseases | 2 | 1987 | 45 | 0.020 |
Why?
|
Neural Inhibition | 1 | 1994 | 589 | 0.020 |
Why?
|
Longitudinal Studies | 3 | 2010 | 14747 | 0.020 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2011 | 322 | 0.020 |
Why?
|
Melanins | 1 | 1992 | 290 | 0.020 |
Why?
|
Pattern Recognition, Visual | 2 | 1986 | 820 | 0.020 |
Why?
|
Kidney Diseases, Cystic | 1 | 2011 | 182 | 0.020 |
Why?
|
Iron | 1 | 1998 | 1811 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2005 | 8924 | 0.020 |
Why?
|
Choroid Neoplasms | 2 | 1980 | 175 | 0.020 |
Why?
|
Models, Biological | 1 | 2005 | 9445 | 0.020 |
Why?
|
Massachusetts | 1 | 2001 | 8882 | 0.020 |
Why?
|
Molecular Sequence Data | 4 | 2003 | 17597 | 0.020 |
Why?
|
Apoptosis | 1 | 2024 | 9508 | 0.020 |
Why?
|
Genes, Recessive | 2 | 2003 | 625 | 0.020 |
Why?
|
Gastrointestinal Diseases | 1 | 1976 | 1204 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 1997 | 2028 | 0.020 |
Why?
|
Microscopy, Electron | 3 | 1982 | 2543 | 0.020 |
Why?
|
RNA Splice Sites | 1 | 2008 | 212 | 0.020 |
Why?
|
Cranial Nerve Neoplasms | 1 | 1988 | 131 | 0.020 |
Why?
|
Osmolar Concentration | 1 | 1988 | 655 | 0.020 |
Why?
|
Vitamin E Deficiency | 1 | 1987 | 30 | 0.020 |
Why?
|
Spinocerebellar Degenerations | 1 | 1987 | 44 | 0.020 |
Why?
|
Prolactin | 1 | 1989 | 626 | 0.020 |
Why?
|
Memory | 1 | 2016 | 2192 | 0.020 |
Why?
|
Cataract | 3 | 1985 | 837 | 0.020 |
Why?
|
Mathematics | 1 | 1988 | 696 | 0.020 |
Why?
|
Oligodendroglioma | 1 | 1988 | 274 | 0.020 |
Why?
|
Contrast Sensitivity | 1 | 1988 | 249 | 0.020 |
Why?
|
Injections | 1 | 2009 | 839 | 0.020 |
Why?
|
Plasma Membrane Neurotransmitter Transport Proteins | 1 | 2006 | 23 | 0.020 |
Why?
|
Eye Neoplasms | 2 | 1978 | 305 | 0.020 |
Why?
|
Societies, Medical | 1 | 2018 | 3955 | 0.020 |
Why?
|
Craniopharyngioma | 1 | 1988 | 276 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2898 | 0.020 |
Why?
|
Language Development Disorders | 1 | 1987 | 194 | 0.020 |
Why?
|
Face | 2 | 1984 | 1029 | 0.020 |
Why?
|
Linear Models | 1 | 1995 | 5873 | 0.010 |
Why?
|
Safety | 1 | 2009 | 1157 | 0.010 |
Why?
|
Amino Acids, Sulfur | 1 | 1984 | 16 | 0.010 |
Why?
|
Malonates | 1 | 1984 | 43 | 0.010 |
Why?
|
Dependovirus | 1 | 2009 | 721 | 0.010 |
Why?
|
Photolysis | 1 | 1984 | 94 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2008 | 59515 | 0.010 |
Why?
|
Fetus | 1 | 1991 | 1878 | 0.010 |
Why?
|
Cholestasis | 1 | 1987 | 385 | 0.010 |
Why?
|
Referral and Consultation | 2 | 2006 | 3617 | 0.010 |
Why?
|
Evolution, Molecular | 2 | 2003 | 1889 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2016 | 7119 | 0.010 |
Why?
|
Form Perception | 1 | 1984 | 175 | 0.010 |
Why?
|
Rodent Diseases | 1 | 1983 | 53 | 0.010 |
Why?
|
Clinical Protocols | 1 | 2008 | 1437 | 0.010 |
Why?
|
Regeneration | 2 | 1988 | 1516 | 0.010 |
Why?
|
Vitamin E | 1 | 1987 | 872 | 0.010 |
Why?
|
Incidence | 1 | 2001 | 21513 | 0.010 |
Why?
|
Psychophysiology | 1 | 1982 | 136 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2008 | 2351 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2013 | 4780 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2016 | 22341 | 0.010 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2003 | 412 | 0.010 |
Why?
|
Occupational Diseases | 2 | 1980 | 1456 | 0.010 |
Why?
|
Microscopy, Electron, Scanning | 2 | 1982 | 938 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2008 | 1536 | 0.010 |
Why?
|
Vitamin B 12 | 1 | 1984 | 531 | 0.010 |
Why?
|
Nerve Degeneration | 1 | 1985 | 748 | 0.010 |
Why?
|
Brain Diseases | 2 | 1987 | 1552 | 0.010 |
Why?
|
Action Potentials | 2 | 1978 | 1834 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2003 | 13400 | 0.010 |
Why?
|
Tuberous Sclerosis | 1 | 1988 | 1039 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2009 | 3400 | 0.010 |
Why?
|
Chemical Industry | 1 | 1980 | 115 | 0.010 |
Why?
|
Pituitary Neoplasms | 1 | 1988 | 1322 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2011 | 3853 | 0.010 |
Why?
|
Synaptic Transmission | 1 | 1985 | 1175 | 0.010 |
Why?
|
Reaction Time | 1 | 1985 | 2086 | 0.010 |
Why?
|
Regression Analysis | 1 | 1988 | 6324 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 1982 | 1748 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2003 | 2743 | 0.010 |
Why?
|
Gene Deletion | 1 | 2006 | 2667 | 0.010 |
Why?
|
Base Sequence | 1 | 2008 | 12405 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 10737 | 0.010 |
Why?
|
Optic Atrophy | 1 | 1977 | 78 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2013 | 9527 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2011 | 12426 | 0.010 |
Why?
|
Iris | 1 | 1977 | 232 | 0.010 |
Why?
|
DNA Primers | 1 | 2001 | 2824 | 0.010 |
Why?
|
Haplotypes | 1 | 2003 | 2726 | 0.010 |
Why?
|
Pyloric Antrum | 1 | 1976 | 66 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2006 | 2235 | 0.010 |
Why?
|
Meningoencephalitis | 1 | 1976 | 82 | 0.010 |
Why?
|
Choristoma | 1 | 1977 | 205 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2006 | 3678 | 0.010 |
Why?
|
Blood Sedimentation | 1 | 1976 | 234 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 2001 | 4163 | 0.010 |
Why?
|
Retinoblastoma | 1 | 1978 | 316 | 0.010 |
Why?
|
Temporal Arteries | 1 | 1976 | 155 | 0.010 |
Why?
|
Eyelids | 1 | 1977 | 278 | 0.010 |
Why?
|
Introns | 1 | 1998 | 965 | 0.010 |
Why?
|
Phylogeny | 1 | 2003 | 2838 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2014 | 16040 | 0.010 |
Why?
|
Evoked Potentials | 1 | 1981 | 1050 | 0.010 |
Why?
|
Phosphorylation | 1 | 2006 | 8292 | 0.010 |
Why?
|
Psychometrics | 1 | 1984 | 3060 | 0.010 |
Why?
|
Ultrasonography | 1 | 1987 | 5988 | 0.010 |
Why?
|
Granuloma | 1 | 1976 | 329 | 0.010 |
Why?
|
Epithelium | 1 | 1978 | 1604 | 0.010 |
Why?
|
Glioma | 1 | 1988 | 3491 | 0.010 |
Why?
|
Choice Behavior | 1 | 1979 | 846 | 0.010 |
Why?
|
Research Design | 1 | 2008 | 6206 | 0.010 |
Why?
|
Microscopy | 1 | 1978 | 900 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 1989 | 15403 | 0.010 |
Why?
|
Prednisone | 1 | 1976 | 1566 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2001 | 6059 | 0.010 |
Why?
|
Melanoma | 2 | 1980 | 5695 | 0.010 |
Why?
|
Leukemia | 1 | 1978 | 1522 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 1998 | 4249 | 0.000 |
Why?
|
Brain Neoplasms | 1 | 1988 | 9065 | 0.000 |
Why?
|
Injections, Intramuscular | 1 | 1987 | 551 | 0.000 |
Why?
|
Epidemiologic Methods | 2 | 1980 | 1325 | 0.000 |
Why?
|
Cystathionine | 1 | 1984 | 6 | 0.000 |
Why?
|
Biopsy | 1 | 1976 | 6768 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 1987 | 20700 | 0.000 |
Why?
|
Accommodation, Ocular | 1 | 1984 | 47 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2009 | 65219 | 0.000 |
Why?
|
West Virginia | 1 | 1980 | 32 | 0.000 |
Why?
|
Growth Disorders | 1 | 1984 | 633 | 0.000 |
Why?
|
Drug Administration Schedule | 1 | 1987 | 4853 | 0.000 |
Why?
|
Nevus | 1 | 1980 | 204 | 0.000 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 1980 | 354 | 0.000 |
Why?
|
Mice, Inbred Strains | 1 | 1976 | 1769 | 0.000 |
Why?
|
Dogs | 1 | 1976 | 3824 | 0.000 |
Why?
|
Risk | 1 | 1982 | 9599 | 0.000 |
Why?
|
Neoplasm Metastasis | 1 | 1980 | 4887 | 0.000 |
Why?
|
Registries | 1 | 1976 | 8347 | 0.000 |
Why?
|